GSK Expects To Restore Avandia Inventory Before Avandamet
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline says supplies of Coreg have returned to normal levels following a shortage at the end of 2005.
You may also be interested in...
Avandamet Supply Issues Are Resolved, Allowing Launch Of New Indication
GlaxoSmithKline's announcement about renewed Avandamet availability follows the approval of the type 2 diabetes drug for first-line use.
Avandamet Supply Issues Are Resolved, Allowing Launch Of New Indication
GlaxoSmithKline's announcement about renewed Avandamet availability follows the approval of the type 2 diabetes drug for first-line use.
Avandamet sNDA Approved For First-Line Use In Type 2 Diabetics
GlaxoSmithKline’s updated label for the rosiglitazone/metformin combination also includes new data concerning risk in congestive heart failure patients.